Comparison of insulin glargine 300 U/mL and insulin degludec using flash glucose monitoring: A randomized cross‐over study
Abstract Aims/Introduction We compared the efficacy and safety of insulin glargine 300 U/mL (Gla300) and insulin degludec U100 (Deg) using a flash glucose monitoring system. Materials and Methods A total of 24 Japanese patients with type 2 diabetes were randomized to receive once‐daily Gla300 (n = 1...
Main Authors: | Mizuho Yamabe, Mami Kuroda, Yasuyo Hirosawa, Hiromi Kamino, Haruya Ohno, Masayasu Yoneda |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-03-01
|
Series: | Journal of Diabetes Investigation |
Subjects: | |
Online Access: | https://doi.org/10.1111/jdi.12894 |
Similar Items
-
United States experience of insulin Degludec alone or in combination for type 1 and type 2 diabetes
by: Rendell M
Published: (2017-04-01) -
Insulin/carbohydrates ratio during the first 6‐month therapy with insulin degludec in a paediatric population with type 1 diabetes previously treated with insulin glargine. An observational longitudinal study
by: Stefano Tumini, et al.
Published: (2020-04-01) -
Insulin degludec
by: Vishakha V Jain, et al.
Published: (2013-01-01) -
Insulin degludec and insulin degludec/insulin aspart in Ramadan: A single center experience
by: Sanjay Kalra
Published: (2016-01-01) -
Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus
by: Lau IT, et al.
Published: (2017-06-01)